GlobalData on MSN5d
FDA to review Sanofi and Regeneron’s Dupixent sBLA for bullous pemphigoid
As Sanofi and Regeneron await the FDA decision, a legal dispute between the partners over commercialisation details continues ...
C&EN16d
MOF UiO-66 Membranes for Pervaporation Prepared by Secondary Growth Using Zr(n-OPr) 4
Chemical Engineering Research Center, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China Tianjin Key Laboratory of Membrane Science and Desalination Technology, ...
Medscape28d
Mucous Aggregate of the Nasopharynx: The Mucolith
Dermatologists often evaluate and treat conditions involving the mucous membranes. This epithelium is present not only in the eye, mouth, and genitalia but also in the nasopharynx. Although ...
BioSpace28d
Bullous Pemphigoid Market Size to Reach USD 1,618.1 Million by 2035, impelled by Rising Incidence of Autoimmune Diseases
Bullous Pemphigoid Market Outlook 2025-2035: The 7 major Bullous Pemphigoid market reached a value of USD 287.1 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 1,618.1 ...